Stability and immunogenicity of empty particles of foot-and-mouth disease virus
- PMID: 218538
- DOI: 10.1007/BF01317896
Stability and immunogenicity of empty particles of foot-and-mouth disease virus
Abstract
Three strains of foot-and-mouth disease virus were shown to contain significant amounts of naturally occurring 75S, empty particles as well as the infectious, 140S full particles. One of these strains--A Pando (1970)--was studied in detail. The empty particles from this virus strain were shown to have an observed sedimentation coefficient of 67S in 0.04 M phosphate buffer; they were labile in SDS, non-infectious and probably RNA-free and, on heating, they broke down to 12S subunits as did the 140S particles. The empty particles differed from the full particles in their polypeptide composition since they contained VP0, but there was no evidence for a diminished content of VP4. The 75S particles were shown to be present in significant amounts and to be stable to AEI inactivation. At 4 degrees C they were stable for at least two years. In guinea pigs they were as immunogenic as the 140S particles. The antisera raised against the 75S particles had the same serological specificity in neutralization tests as sera prepared against the 140S particle. It was concluded that the 75S particles from the A Pando (1970) strain of FMD virus may provide as important a contribution as 140S particles to the immunogenicity of inactivated vaccines prepared from this virus strain.
Similar articles
-
A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus.J Gen Virol. 1975 Mar;26(3):227-38. doi: 10.1099/0022-1317-26-3-227. J Gen Virol. 1975. PMID: 235596
-
Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.Vaccine. 1995 Nov;13(16):1603-10. doi: 10.1016/0264-410x(95)00079-g. Vaccine. 1995. PMID: 8578849
-
Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.J Gen Virol. 1986 Oct;67 ( Pt 10):2083-92. doi: 10.1099/0022-1317-67-10-2083. J Gen Virol. 1986. PMID: 2428926
-
Foot-and-mouth disease and its antigens.Adv Exp Med Biol. 1985;185:27-46. doi: 10.1007/978-1-4684-7974-4_2. Adv Exp Med Biol. 1985. PMID: 2416203 Review.
-
Use of peptides for immunization against foot-and-mouth disease.Vaccine. 1988 Apr;6(2):180-2. doi: 10.1016/s0264-410x(88)80024-0. Vaccine. 1988. PMID: 2838987 Review.
Cited by
-
Development of Foot-and-Mouth Disease Vaccines in Recent Years.Vaccines (Basel). 2022 Oct 28;10(11):1817. doi: 10.3390/vaccines10111817. Vaccines (Basel). 2022. PMID: 36366327 Free PMC article. Review.
-
Foot-and-mouth disease.Clin Microbiol Rev. 2004 Apr;17(2):465-93. doi: 10.1128/CMR.17.2.465-493.2004. Clin Microbiol Rev. 2004. PMID: 15084510 Free PMC article. Review.
-
An overview on ELISA techniques for FMD.Virol J. 2011 Sep 4;8:419. doi: 10.1186/1743-422X-8-419. Virol J. 2011. PMID: 21888667 Free PMC article. Review.
-
Research in advance for FMD novel vaccines.Virol J. 2011 Jun 3;8:268. doi: 10.1186/1743-422X-8-268. Virol J. 2011. PMID: 21635788 Free PMC article. Review.
-
Thermal stability of foot-and-mouth disease virus.Arch Virol. 1981;70(1):21-32. doi: 10.1007/BF01320790. Arch Virol. 1981. PMID: 6277281
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources